SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-19-122589
Filing Date
2019-04-26
Accepted
2019-04-26 17:00:34
Documents
6
Period of Report
2019-06-03
Effectiveness Date
2019-04-26

Document Format Files

Seq Description Document Type Size
1 DEF 14A d730865ddef14a.htm DEF 14A 572109
2 GRAPHIC g730865g45c69.jpg GRAPHIC 26810
3 GRAPHIC g730865g51v60.jpg GRAPHIC 57482
4 GRAPHIC g730865g82c65.jpg GRAPHIC 34336
5 GRAPHIC g730865img01.jpg GRAPHIC 416756
6 GRAPHIC g730865img02.jpg GRAPHIC 230405
  Complete submission text file 0001193125-19-122589.txt   1628309
Mailing Address 9 HA'TA'ASIYA ST RA'ANANA L3 4365007
Business Address 9 HA'TA'ASIYA ST RA'ANANA L3 4365007 972 9 770 7601
UroGen Pharma Ltd. (Filer) CIK: 0001668243 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38079 | Film No.: 19772603
SIC: 2834 Pharmaceutical Preparations